CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $251,000 | -33.4% | 210,958 | +0.5% | 0.00% | – |
| Q2 2022 | $377,000 | -26.7% | 209,892 | -17.5% | 0.00% | – |
| Q1 2022 | $514,000 | -89.0% | 254,319 | -85.2% | 0.00% | – |
| Q4 2021 | $4,669,000 | +1293.7% | 1,722,801 | +2194.3% | 0.00% | – |
| Q3 2021 | $335,000 | -41.8% | 75,090 | -24.3% | 0.00% | – |
| Q2 2021 | $576,000 | -50.9% | 99,258 | -40.6% | 0.00% | – |
| Q1 2021 | $1,173,000 | -24.2% | 167,080 | -48.2% | 0.00% | – |
| Q4 2020 | $1,548,000 | +84.3% | 322,570 | +123.6% | 0.00% | – |
| Q3 2020 | $840,000 | -63.1% | 144,256 | -57.2% | 0.00% | – |
| Q2 2020 | $2,275,000 | +14.4% | 337,115 | +7.9% | 0.00% | – |
| Q1 2020 | $1,988,000 | -88.5% | 312,518 | -81.2% | 0.00% | -100.0% |
| Q4 2019 | $17,351,000 | +1924.6% | 1,664,368 | +663.8% | 0.00% | – |
| Q3 2019 | $857,000 | -87.8% | 217,920 | -53.9% | 0.00% | -100.0% |
| Q2 2019 | $7,036,000 | -31.3% | 473,111 | +14.7% | 0.00% | 0.0% |
| Q1 2019 | $10,240,000 | +77.9% | 412,570 | +28.8% | 0.00% | 0.0% |
| Q4 2018 | $5,755,000 | -62.9% | 320,389 | -39.3% | 0.00% | -50.0% |
| Q3 2018 | $15,509,000 | -47.9% | 528,019 | -19.4% | 0.00% | -50.0% |
| Q2 2018 | $29,776,000 | +36.8% | 654,834 | +58.9% | 0.00% | +33.3% |
| Q1 2018 | $21,762,000 | -62.3% | 412,127 | -51.5% | 0.00% | -70.0% |
| Q4 2017 | $57,783,000 | -12.2% | 849,737 | +6.4% | 0.01% | 0.0% |
| Q3 2017 | $65,829,000 | -27.0% | 798,893 | -17.0% | 0.01% | -44.4% |
| Q2 2017 | $90,145,000 | +200.0% | 962,775 | +104.0% | 0.02% | +200.0% |
| Q1 2017 | $30,045,000 | +3604.7% | 471,885 | +2483.3% | 0.01% | – |
| Q4 2016 | $811,000 | -93.2% | 18,267 | -94.5% | 0.00% | -100.0% |
| Q3 2016 | $11,921,000 | +11941.4% | 330,664 | +4467.2% | 0.00% | – |
| Q2 2016 | $99,000 | -93.2% | 7,240 | -90.4% | 0.00% | – |
| Q1 2016 | $1,454,000 | +54.4% | 75,750 | +181.5% | 0.00% | – |
| Q4 2015 | $942,000 | +13.2% | 26,912 | +197.7% | 0.00% | – |
| Q3 2015 | $832,000 | -1.7% | 9,040 | -6.1% | 0.00% | – |
| Q2 2015 | $846,000 | +338.3% | 9,625 | +269.5% | 0.00% | – |
| Q1 2015 | $193,000 | -38.1% | 2,605 | -53.3% | 0.00% | – |
| Q4 2014 | $312,000 | +26.8% | 5,578 | +2.9% | 0.00% | – |
| Q3 2014 | $246,000 | -41.6% | 5,422 | -46.6% | 0.00% | – |
| Q2 2014 | $421,000 | -77.7% | 10,159 | -62.7% | 0.00% | -100.0% |
| Q1 2014 | $1,889,000 | +9.1% | 27,268 | -5.1% | 0.00% | 0.0% |
| Q4 2013 | $1,731,000 | -3.8% | 28,726 | -3.0% | 0.00% | 0.0% |
| Q3 2013 | $1,800,000 | -5.2% | 29,609 | +4.5% | 0.00% | 0.0% |
| Q2 2013 | $1,898,000 | – | 28,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |